Brief: N4 Pharma PLC Says Operating Loss For Year Reduced To £1,029,261
March 9 (Reuters) - N4 Pharma PLC N4P.L :
* N4 PHARMA PLC - OPERATING LOSS FOR YEAR WAS REDUCED TO
£1,029,261 (2021: £1,843,290)
Source text for Eikon: urn:newsml:reuters.com:*:nRSI3561Sa
Further company coverage: N4P.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results